Skip to main content

Graph of the Month

Immunotherapy and PBT

24 July 2020

The combination of proton therapy with immunotherapy is considered promising and has gained substantial interest over the last 2 years. According to Prof Justin Stebbing, an internationally acclaimed expert in immunotherapies for cancer, “the synergies between immunotherapy and radiotherapy can potentially allow for better treatment of cancers, improving both quality and quantity of life.” A recent paper published in the British Journal of Radiology shows that proton therapy might be better adapted to for combination with immunotherapy because it causes less damage to the immune cells and induces a stronger immune response due to a different cell death mechanism.

Ahead of the ASTRO conference in October

25 June 2020

FLASH continues to prove its unique advantages in healthy tissue sparing with tumour control even in radioresistant cases. The LIGHT system is uniquely suited to application of FLASH at all depths. Currently we are investigating the delivery FLASH dose rates for a wide range of spot sizes. Follow us at upcoming ASTRO for more details!